British women may be at risk from PIP implants sold under a different name
06 | 01 | 12
It has emerged that thousands more
women may be at risk following an announcement, which found that
the implants made by Poly Implant Prothese (PIP) have also been
sold by Dutch manufacturer Rofil.
The faulty PIP implants are the
subject of a Medical Device Alert (MDA) by the Medicines and
Healthcare products Regulatory Agency (MHRA), with a recall being
issued on March 31 2010 for all UK implants. The implants were
recalled following concerns relating to an increase in rupture
rates in these implants.
The failure rate for UK patients
has been defined by the MHRA as being 1%, whereas French
authorities have found that the implants have a 5% rupture rate and
a major UK private clinic has reported that the failure rate
amongst its patients is at 7%.
Whilst the Rofil implant was not
sold in British clinics, it’s estimated that more than 5000 British
woman may have the implant following cut-price surgery abroad in
countries such as Belgium, Poland and the Czech Republic.
Rofil, the Dutch implant
manufacturer is believed to have had a long-standing agreement to
buy implants from PIP, which were rebranded as M-implants.
Women all over the UK affected by
the PIP breast implant recall are awaiting a statement from the
Government on the PIP breast implant scandal, with a decision
imminent.
Mark Harvey, Partner and Head of
Litigation at Hugh James solicitors is representing over 600 women
with PIP implants of which over 300 have contacted Hugh James in
the last two weeks.
View
our PIP news articles archive
For information on joining the
group represented by Mark Harvey please contact Hugh James on 02920
224 871 or complete the enquiry
form.